Trius Study site 007 — San Francisco, California

Trius Study site 007 is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Trius Study site 007 has participated in 1 clinical trials.

Therapeutic areas: Skin Diseases, Infectious, Skin Diseases, Bacterial.

Sponsors: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trius Study site 007?

Trius Study site 007 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trius Study site 007 conducted?

Trius Study site 007 has 1 clinical trials on record. Their work covers Skin Diseases, Infectious, Skin Diseases, Bacterial.

Is Trius Study site 007 accredited by Crixeo Health?

Trius Study site 007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trius Study site 007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.